SCHEMBL4698122

SCHEMBL4698122

N#CCCN(CCC#N)c1ccc(C=O)cc1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
ALDH1A3 P47895 3/20 0.55
ALDH3A1 P30838 2/20 0.55
CYP2A6 P11509 1/20 0.44
CYP2A13 Q16696 1/20 0.44
EGFR P00533 2/20 0.40
TDP2 O95551 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
USP2 O75604 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9836517 0.98 ALDH1A1 (0.53) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL11696300 0.92 ALDH3A1 (0.56) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL11699067 0.92 ALDH1A1 (0.47) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL11087044 0.92 ALDH1A1 (0.47) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL8722764 0.91 ALDH1A1 (0.65) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL11693865 0.87 ALDH1A1 (0.42) ALDH1A1ALDH1A3ALDH3A1CYP2A6TDP2
SCHEMBL11581148 0.85 POLB (0.46) ALDH1A1ALDH1A3ALDH3A1MEN1POLB
SCHEMBL538121 0.82 ALDH1A1 (0.50) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL11692386 0.82 TDP2 (0.40) ALDH1A1ALDH1A3ALDH3A1TDP2POLB
SCHEMBL11698911 0.81 ALDH1A1 (0.44) ALDH1A1ALDH1A3ALDH3A1TDP2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12235217-B2 Diagnostic test kits for sample preparation and analysis SCANWELL HEALTH, INC. (US) 2025-02-25 US claimed
EP-4058775-A1 DIAGNOSTIC TEST KITS FOR SAMPLE PREPARATION AND ANALYSIS Scanwell Health, Inc. (US) 2022-09-21 EP claimed
CN-114981637-A Diagnostic test kit for sample preparation and analysis 斯肯威尔健康公司 2022-08-30 CN claimed
US-20210231574-A1 DIAGNOSTIC TEST KITS FOR SAMPLE PREPARATION AND ANALYSIS SCANWELL HEALTH, INC. 2021-07-29 US claimed
WO-2021097343-A1 DIAGNOSTIC TEST KITS FOR SAMPLE PREPARATION AND ANALYSIS SCANWELL HEALTH, INC. (US) 2021-05-20 WO claimed
US-20040132807-A1 Aurones as telomerase inhibitors PHARMACIA ITALIA SPA (IT) 2004-07-08 US claimed
US-6336963-B1 INK COMPOSITION COMPRISING INK VEHICLE COMPRISING FIRST NITRILE COMPOUND HAVING FIRST VISCOSITY AT MELT TEMPERATURE, VISCOSITY MODIFIER COMPRISING SECOND NITRILE COMPOUND HAVING LOWER VISCOSITY AT MELT TEMPERATURE, COLORANT XEROX CORPORATION 2002-01-08 US claimed
EP-0743574-B1 Migration imaging members XEROX CORP (US) 2000-12-27 EP claimed
EP-0743573-B1 Method for obtaining image contrast migration imaging members XEROX CORP (US) 2000-09-06 EP claimed
EP-0743574-A2 Migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
EP-0743573-A2 Method for obtaining image contrast migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
US-5563014-A SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT XEROX CORPORATION (US) 1996-10-08 US claimed
US-5514505-A SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE XEROX CORPORATION (US) 1996-05-07 US claimed
US-20250258104-A1 DIAGNOSTIC TEST KITS FOR SAMPLE PREPARATION AND ANALYSIS SCANWELL HEALTH INC (US) 2025-08-14 US disclosed
US-12235217-B2 Diagnostic test kits for sample preparation and analysis SCANWELL HEALTH, INC. (US) 2025-02-25 US disclosed
EP-4058775-A1 DIAGNOSTIC TEST KITS FOR SAMPLE PREPARATION AND ANALYSIS Scanwell Health, Inc. (US) 2022-09-21 EP disclosed
US-4115126-A Magenta triphenylmethane antihalation dyes for photographic elements E. I. DU PONT DE NEMOURS AND COMPANY (US) 1978-09-19 US disclosed
US-4002616-A POLYESTERS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-01-11 US disclosed
US-3962220-A ONE-STEP, AROMATIC ALDEHYDES, ACETIC ACID E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-06-08 US disclosed
US-3962221-A CONDENSATION, REDUCTION, OXIDATION E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132807-A1 Aurones as telomerase inhibitors TERT, TERF2, TERF2IP ALDH1A1 1344/4885ALDH1A3 2513/4885ALDH3A1 2459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.